Approvals/TGA/ZolaCos CP Combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack

Approved

STANDARD

ZolaCos CP Combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 97251a716b52170f
Product Name: ZolaCos CP Combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack
Artg Id: 125685
Artg Name: ZolaCos CP combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister pack
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2006-12-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-06003-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-06002-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

97251a716b52170f

Type

Standard